Axon Biotech GmbH
Medical Technology · Deggendorf
Axon Biotech GmbH is a medical technology company based in Deggendorf, Germany. The company operates in the German medical devices market under the EU Medical Device Regulation (MDR 2017/745).
Content in German
The detailed company information on this page is provided in the original German language. You can use your browser's built-in translation feature to view it in English.
Right-click on the page and select "Translate to English" or use the translation icon in your browser's address bar.
Axon Biotech GmbH Address & Contact
Website
Axon Biotech GmbH Overview
Axon Biotech GmbH is a biotechnology and life sciences company from Deggendorf in Bavaria, specializing in cell culture systems and neuroscience research tools. The company develops and produces multiwell electrode arrays (MEA) and culture systems for neuronal network research. Through innovative technologies and continuous research, Axon Biotech is able to provide pioneering solutions for challenges in biomedicine while contributing to the scientific community.
Services and Products
Axon Biotech produces multiwell MEA systems for extracellular recordings from neurons and cardiomyocytes, culture systems for 3D cell cultures, as well as software for signal analysis and data acquisition. These products are particularly valuable for pharmacology, toxicology, and neuroscience research, as they provide precise data for the study of cellular activity.
- Multiwell Electrode Arrays (MEA): These arrays enable real-time monitoring of neuronal activities and their responses to various stimuli.
- Culture Systems for 3D Cell Cultures: They provide a natural environment for cells, leading to more realistic outcomes and improved cell interactions.
- Software Solutions: The specially designed analysis tools assist researchers in evaluating complex data and provide user-friendly interfaces to facilitate data acquisition.
These products are not only crucial in basic research but also in the development of new therapeutic approaches. Compliance with regulatory standards is a matter of course for Axon Biotech, ensuring that the products meet the stringent requirements of the medical technology industry and are accepted internationally.
Regulatory Classification
The products of Axon Biotech are subject to strict regulatory requirements. Compliance with quality standards according to ISO 13485 for medical technology is ensured, which guarantees absolute reliability and safety of the offered products. In addition, the company has obtained a number of CE certifications for its products, allowing them to operate in the European market and meet the needs of their customers in research and industry. This regulatory compliance underscores the company's commitment to the highest quality standards.
Regional Importance
Deggendorf, an emerging location in Lower Bavaria, offers Axon Biotech a strategic position for networking with other companies and research institutions in the field of life sciences. The proximity to the Deggendorf University of Applied Sciences, which has an excellent reputation in biotechnology and medical technology, promotes the exchange of knowledge and innovations. Furthermore, the location near the Czech border facilitates collaboration with international research institutions and companies, further enhancing innovation potential.
Distinct Features of Axon Biotech
A central feature of Axon Biotech is the combination of technical expertise and an interdisciplinary approach. The company is not only active in research but also offers customized solutions for scientists and researchers with specific requirements for cell culture and electrode applications. This ability to address individual needs ensures that the products are optimally adapted to the respective research conditions.
Additionally, Axon Biotech regularly invests in research and development to create new products and technologies that meet the ever-changing demands of the market. The company relies on close collaborations with universities and research institutions to remain at the forefront of scientific development of new approaches.
Other medical technology companies: Medical Technology Overview | Medical Technology Bavaria | Laboratories
Frequently asked questions about Axon Biotech GmbH
What does Axon Biotech GmbH do?
Über Axon Biotech GmbH Axon Biotech GmbH ist ein Unternehmen, das sich auf die Bereitstellung von Lösungen im Bereich der biotechnologischen Forschung und Entwicklung ko
Where is Axon Biotech GmbH located?
Axon Biotech GmbH is based in Deggendorf (Bayern). Detailed contact information, address and telephone number can be found on this page.
In which field does Axon Biotech GmbH operate?
Axon Biotech GmbH operates in the medical technology sector and offers specialised products and services for the German healthcare system.
Axon Biotech GmbH on social media
More Medical Technology in Deggendorf
Medical Technology in Germany
Related areas in healthcare
Medical Technology by location
About Medical Technology
Germany's medical technology sector is one of the most important in the world. With annual revenues of approximately EUR 36 billion and more than 1,400 companies, Germany ranks as the third-largest medical technology market globally (SPECTARIS 2023), after the United States and Japan. The sector encompasses the development, manufacture and distribution of an extraordinarily wide range of products: in-vitro diagnostic (IVD) devices, medical imaging systems (CT, MRI, ultrasound), implants such as hip and knee prostheses, cardiac pacemakers, surgical instruments, hospital beds, wound care products and medical software classified as a Software as a Medical Device (SaMD). In Germany and across the European Union, medical devices must comply with the EU Medical Device Regulation (MDR 2017/745), which replaced the former Medical Devices Directive (MDD 93/42/EEC). Devices are classified into risk classes I, IIa, IIb and III. Higher-risk classes require a conformity assessment by a designated Notified Body (benannte Stelle) before a CE mark can be affixed. The CE mark signals that the product meets EU safety, performance and quality requirements and may be placed on the European market. Key medtech clusters in Germany include the Munich and Nuremberg region in Bavaria, the Rhine-Main area in Hesse, Tuttlingen in Baden-Württemberg (known as the world capital of surgical instruments) and the Hamburg metropolitan area. This directory lists CE-certified manufacturers, distributors and suppliers across the German medtech sector with full contact details.
Germany as a Global Medical Technology Hub
Germany's position as the world's third-largest medical technology market is underpinned by a combination of industrial engineering excellence, a well-funded healthcare system and a highly productive research landscape. The German medtech sector is characterised by a large number of small and medium-sized enterprises (SMEs) that are often hidden champions (Weltmarktführer) in specialised niches. Unlike the pharmaceutical sector, where large corporations dominate, the medtech industry is more fragmented and innovative, with frequent spin-offs from university hospitals and engineering faculties. Key product categories include imaging systems (MRI, CT, X-ray, ultrasound), endoscopy and minimally invasive surgical tools, orthopaedic implants, cardiovascular devices, in-vitro diagnostics, dental equipment, ophthalmic devices, wound care systems and hospital IT and medical software. Germany is particularly renowned for its surgical instrument manufacturing, centred in Tuttlingen, Baden-Württemberg, which supplies operating theatres worldwide. The annual Medica trade fair in Düsseldorf is the world's largest medical technology exhibition and serves as a global industry showcase.
EU MDR Compliance and CE Marking for German Manufacturers
The EU Medical Device Regulation (MDR 2017/745) replaced the former Medical Devices Directive (MDD 93/42/EEC) and has applied in full since May 2021, with transition periods for legacy devices extended to 2028 in some cases. For German manufacturers selling in the EU market, MDR compliance is a legal necessity. The regulation introduced significantly strengthened requirements compared to the old MDD: more rigorous clinical evidence requirements, mandatory post-market clinical follow-up (PMCF), unique device identification (UDI) registration in the EUDAMED database, increased obligations for Notified Bodies, and stricter rules for software as a medical device (SaMD). The risk classification system under MDR uses four classes (I, IIa, IIb, III) based on the intended purpose, duration of use and body contact of the device. Manufacturers must appoint an authorised representative in the EU if they are not themselves based in an EU member state, and they must maintain a quality management system. In Germany, the Bundesnetzagentur and state authorities support MDR enforcement alongside BfArM.
Innovation and Research in German Medtech
Germany's medtech innovation ecosystem benefits from close collaboration between industry, university hospitals (Universitätsklinika), applied research institutes (such as those of the Fraunhofer and Helmholtz networks) and health technology assessment bodies. The Federal Joint Committee (Gemeinsamer Bundesausschuss, G-BA) and the Institute for Quality and Efficiency in Health Care (Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen, IQWiG) play important roles in assessing which new medical technologies are eligible for reimbursement by statutory health insurance (GKV). This reimbursement pathway, known as the NUB process (Neue Untersuchungs- und Behandlungsmethoden) for hospital technologies, is a key milestone for commercial success in Germany. Innovative devices that receive a positive NUB assessment can be reimbursed at negotiated rates by statutory insurers, providing a significant market access advantage.
Innovation Fields and Future Technologies
The German medical technology sector is driving numerous future fields forward. AI-supported diagnostics and image analysis are revolutionising radiology and pathology; algorithms for the early detection of cancer and cardiovascular disease are increasingly receiving CE approvals as Software as a Medical Device (SaMD). Robot-assisted surgical systems, led by products from Siemens Healthineers, Brainlab and Karl Storz, are improving precision in complex procedures. Minimally invasive technologies, implantable pacemakers and intelligent prostheses with sensory feedback demonstrate the breadth of innovation. Point-of-care diagnostics enables rapid tests directly in the doctor's surgery or at the bedside. Telemedicine and digital patient records promote networking between medical devices and clinical workflows. The Federal Ministry of Education and Research (BMBF) funding programme specifically supports the development of innovative medical technology products through cooperation between industry and universities.
What does the medical technology sector cover?
Medical technology encompasses the development, manufacture and distribution of medical devices, instruments, software and accessories used to diagnose, prevent, monitor or treat diseases. Germany ranks among the world's leading medical technology hubs.
How are medical devices approved in Germany?
Medical devices in Germany and the EU must comply with the EU Medical Device Regulation (MDR 2017/745) and carry the CE mark. Depending on the risk class, conformity assessments by notified bodies are required.
Where can I find medical technology companies in Germany?
Medical technology companies in Germany can be found through industry associations such as SPECTARIS, BVMed or ZVEI, and via the EUDAMED EU database for registered manufacturers. Sanoliste provides a searchable directory of manufacturers, distributors and suppliers across the German medical technology sector.
How many medical technology companies are there in Germany?
Germany has more than 1,400 medical technology companies generating annual revenues of approximately EUR 36 billion (SPECTARIS 2023), making it the third-largest medical technology market in the world. The majority of companies are small and medium-sized enterprises (SMEs), many of which are world market leaders in their niche.
What are the risk classes for medical devices under the EU MDR?
The EU Medical Device Regulation (MDR 2017/745) classifies medical devices into four risk classes: Class I (lowest risk, e.g. bandages, glasses frames), Class IIa (medium risk, e.g. hearing aids, contact lenses), Class IIb (higher medium risk, e.g. infusion pumps, ventilators) and Class III (highest risk, e.g. implantable cardiac devices, neurosurgical instruments). Higher classes require more rigorous conformity assessment by a Notified Body.
Where are the main medical technology clusters in Germany?
Germany's medical technology industry is concentrated in several regional clusters. Bavaria (particularly Munich and Nuremberg) and Baden-Württemberg (notably Tuttlingen, globally known for surgical instruments) are the two strongest regions. Other significant clusters include the Rhine-Main area in Hesse, the Hamburg metropolitan region, the Ruhr area in North Rhine-Westphalia and the Berlin-Brandenburg region.
What is a Notified Body (benannte Stelle) and why does it matter?
A Notified Body (benannte Stelle) is an independent third-party organisation designated by an EU member state to assess whether medical devices meet the requirements of the MDR before they can carry the CE mark. For Class IIa, IIb and III devices, manufacturers must have their quality management system and technical documentation assessed by a Notified Body. In Germany, the Federal Institute for Drugs and Medical Devices (BfArM) oversees market surveillance, while several German organisations hold Notified Body status under the MDR.